YL
ProThera Biologics Pipeline
| Drug | Indication | Phase |
|---|---|---|
| IAIP Therapy | Severe Community Acquired Pneumonia | Pre-clinical |
| IAIP Therapy & Biomarker | Neonatal Sepsis | Pre-clinical |
| Drug | Indication | Phase |
|---|---|---|
| IAIP Therapy | Severe Community Acquired Pneumonia | Pre-clinical |
| IAIP Therapy & Biomarker | Neonatal Sepsis | Pre-clinical |